|
This new conference on the Genomics of Brain Disorders will bring together researchers working on neurodegenerative and psychiatric diseases for the first time to compare approaches and emerging lessons. The aim is to encourage practitioners of neuroscience, systems biology, bioinformatics, epidemiology and genomics to discuss and debate the challenges and opportunities that lie ahead.
Psychiatric disorders, such as schizophrenia and depression, and neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease, are placing an increasing burden on the developed world. Technical advances over the past five years, including genome-wide association studies and new generation sequencing studies, have led to the discovery of many predisposing loci for both psychiatric and neurodegenerative disorders.
This meeting will summarize the advances and remaining challenges in the genomics of various brain disorders, focusing on the lessons from each field and charting the way forward. We will discuss recent insights into genomic architecture and the emerging biology of disease. We will consider how best to gain biological understanding from both common and rare allele findings and explore the translational and clinical applications, focusing on early detection of risk, biomarkers and stratified medicine.
Further information will be available shortly on our website. Please contact the conference organizer to register your interest in attending this meeting.
|
